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After cell fate specification, differentiating cells must amplify the specific subcellular features required for 
their specialized function. How cells regulate such subcellular scaling is a fundamental unanswered question. 
Here, we show that the E3 ubiquitin ligase Mindbomb 1 (MIB1) is required for the apical secretory apparatus 
established by gastric zymogenic cells as they differentiate from their progenitors. When Mib1 was deleted, 
death-associated protein kinase–1 (DAPK1) was rerouted to the cell base, microtubule-associated protein 1B 
(MAP1B) was dephosphorylated, and the apical vesicles that normally support mature secretory granules were 
dispersed. Consequently, secretory granules did not mature. The transcription factor MIST1 bound the first 
intron of Mib1 and regulated its expression. We further showed that loss of MIB1 and dismantling of the api-
cal secretory apparatus was the earliest quantifiable aberration in zymogenic cells undergoing transition to 
a precancerous metaplastic state in mouse and human stomach. Our results reveal a mechanistic pathway by 
which cells can scale up a specific, specialized subcellular compartment to alter function during differentiation 
and scale it down during disease.
Introduction
Once a cell commits to a specific cell fate and differentiates, it 
must be able to amplify the specific subcellular machinery it 
needs to perform its specialized cell function. Such specification 
requires scaling up the expression of genes that promote those 
processes. Recent work has identified a handful of transcription 
factors whose expression programs and drives the upregulation 
of defined subcellular processes, regardless of cell type. We have 
termed such transcriptional regulators scaling factors (1). For exam-
ple, x-box binding protein 1 (XBP1) is necessary and sufficient 
to induce ER formation in diverse cells such as antigen-secreting 
plasma cells (2, 3) and gastric zymogenic cells (ZCs) (4), and the 
BHLH-ZIP transcription factor TFEB upregulates lysosome for-
mation in diverse cell types (5, 6). In the absence of these factors, 
cells still adopt the correct fates and make ER and lysosomes, but 
they are unable to amplify the subcellular components that are 
key to their specialized mature functions. How such transcrip-
tional regulators can induce changes in specific subcellular com-
partments simply by modulating expression levels of specific gene 
cohorts is a complex problem that is fundamental to understand-
ing how cells develop and maintain their specialized physiological 
functions, particularly how these cellular decisions and functions 
are organized in a tissue under homeostatic conditions and per-
turbed during pathologic conditions.
The adult mammalian gastric epithelium undergoes constant 
renewal throughout life, providing a useful system for studying the 
role of scaling factors and developmentally regulated genes during 
cell maturation in the adult. For example, as mucus-secreting neck 
cells in the middle portion of the gastric unit (i.e., the neck) mature, 
they migrate toward the unit’s base, at which point they undergo a 
series of substantial morphological changes that culminate in the 
formation of postmitotic, digestive enzyme–secreting ZCs (Figure 
1A). The molecular processes underlying this elaborate transition 
are of particular relevance, as alterations in neck cell–ZC differen-
tiation occur during gastric atrophy and metaplasia, processes that 
predispose to cancer (7–11). Stomach cancer is the fourth most 
common and second most fatal malignancy worldwide; however, 
the molecular and morphological progressions that cause this 
malignancy are unclear (12–14).The transcription factor MIST1 
(encoded by Mist1; also known as Bhlha15) is critical for regulating 
normal neck cell–to–ZC maturation, and its expression is lost in 
gastric epithelial atrophy and metaplasia in both humans and mice 
(7, 15, 16). Thus, MIST1 may play a protective role.
Loss of MIST1 affects ZC maturation (16). During maturation 
of ZCs, which are exocrine secretory cells, the subcellular region 
between their nuclei and the apical lumen, into which the secre-
tion of digestive enzymes is directed, is greatly expanded. This 
apical expansion is likely critical for maintenance of the stores of 
secretory granules that must be released upon agonist stimulation; 
however, neither the functional significance nor the molecular 
underpinnings of this maturational scaling process have been elu-
cidated. Here, we present evidence that MIST1 directs the matura-
tion of secretory granules and the apical expansion in ZCs by acti-
vating the expression of Mindbomb 1 (MIB1), a multidomained 
RING-finger type E3 ubiquitin ligase that is conserved from 
Drosophila to mammals (17–20). MIB1 is abundantly expressed 
throughout development and in adult tissues (21). In mammals, 
MIB1 was originally described as the key factor mediating the 
subcellular localization and turnover of death-associated protein 
kinase–1 (DAPK1) (21, 22). In addition, during embryonic devel-
opment, MIB1 ubiquitinates the Notch ligands Delta and Jagged, 
rendering them competent to signal to and activate Notch in adja-
cent cells (19, 23–27). Thus, the role of MIB1 in cells in culture and 
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Figure 1
Microtubules and MAP1B coordinate apical 
compartment expansion and endolysosom-
al trafficking in gastric ZCs. (A) Morphologi-
cal changes that take place as neck cells 
secreting mucus (small white granules) 
differentiate into ZCs secreting zymogen 
(large black granules). The cells are oriented 
with the gastric lumen at the top and the 
basement membrane at the bottom. Arrows 
indicate vectors of expansion or contraction 
during the maturation process. (B) Repre-
sentative section of the base zone of the 
gastric unit (thick dashed outline) stained 
for anti–α-tubulin (green) antibodies and 
Hoechst (blue, nuclei; thin dashed or solid 
outlines). A single ZC is highlighted (solid 
outline). (C) Fluorescent microscopy of the 
neck, transition (TZ), and base zones of the 
gastric unit from wild-type mice stained with 
antibodies against GSII (red, neck cells) 
and CI-M6PR (green; left) and cathepsin L 
(green; right). Neck cells and ZCs (solid 
outline) are shown enlarged in the insets. 
Expression of CI-M6PR and cathepsin L in 
transitional cells and parietal cells is indi-
cated by arrowheads and arrows, respec-
tively. (D) Fluorescent microscopy of gas-
tric unit from wild-type mice stained with 
GSII (magenta, neck cells), anti–α-tubulin 
(green), and anti-MAP1B (red). Enlarged 
views of individual neck cell, parietal cell, 
and ZC stained with α-tubulin and MAP1B, 
as well as merged images, are shown in 
the insets. Scale bars: 5 μm (B; C and D, 
insets), 10 μm (C and D).
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in early embryonic development is well delineated, but how MIB1 
governs the homeostasis or maturation of terminally differenti-
ated cells in the adult organism remains unclear.
Here, we took advantage of the spatiotemporally ordered devel-
opment of the gastric ZC lineage to study the cellular and molec-
ular mechanisms underlying the expansion and maturation of 
the apical cytoplasmic compartment. We found that deletion of 
MIB1 specifically in adult mature ZCs caused abnormal subcel-
lular localization of DAPK1, loss of phosphorylated apical MAP1B 
(encoded by Mtap1b), apical reorientation of nuclei, and defective 
late endosome trafficking. We showed that MIST1 bound to the 
5′ regulatory region of Mib1, and loss of MIST1 caused loss of ZC-
specific MIB1 expression, mislocalization of DAPK1 in ZCs, and 
abrogation of the MIB1-DAPK1 protein interaction. Relevant to 
cancer progression, we showed using mouse models and human 
specimens that loss of MIB1 expression, and dismantling of the 
apical digestive enzyme secretory apparatus, was the earliest 
detectable aberration in ZCs undergoing spasmolytic polypep-
tide–expressing metaplasia (SPEM). Indeed, scaling down of the 
MIB1-regulated apical secretory apparatus predated upregulation 
of mucous neck cell proteins like spasmolytic polypeptide (also 
known as TFF2), which is how this lesion was named and has been 
traditionally diagnosed. The present study is the first to describe 
a molecular mechanism that regulates a prosecretory apical com-
partment in physiologically mature cells, as well as a function for 
MIB1 both in the normal stomach and en route to cancer.
Results
The apical compartment specifically expands during ZC maturation. As 
mucous neck cells migrate into the base segment of the gastric 
unit, they undergo a series of well-characterized, highly coordi-
nated morphological changes that culminate in the formation of 
postmitotic, digestive enzyme–producing ZCs (7, 16, 28). Vectors 
associated with changes in architecture during ZC maturation are 
shown in Figure 1A. During maturation, the luminal apex of the 
ZC shows concentration of subcortical F-actin and nonmuscle 
myosin II, while the basal membrane expands with the establish-
ment of integrin–extracellular matrix connections (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI65703DS1). Concomitant with these processes, 
the apical compartment of the cell expands greatly, as the cells 
enlarge with digestive enzyme–secretory vesicles and the nucleus 
migrates to the base.
In the current study, we focused on the cellular and molecu-
lar mechanisms that lead to the dramatic expansion of the api-
cal region of the cell. Our hypothesis was that maturation and 
expansion of the apical cellular compartment is a fundamental 
cell process that facilitates the large-capacity polarized storage 
and regulated secretion of digestive enzymes key to the physi-
ology of these cells. To understand how changes in the apical 
cytoplasmic compartment are coordinated at the genetic level, 
we performed gene expression profiling: RNA from purified 
populations of neck cells and ZCs was isolated using multila-
bel, RNA-preserving laser capture microdissection (LCM) (16), 
linearly amplified, and hybridized to Affymetrix Mouse Gene 
1.0ST arrays. Genes whose expression was enriched in ZCs com-
pared with neck cells were identified, and 2,935 such ZC-specific 
genes were generated and sorted based on Gene Ontology (GO) 
using GOurmet software (29, 30). The fractional representation 
of genes categorized by the GO term “microtubule” was over-
represented in ZCs (Table 1). Gene expression of α-tubulin in 
ZCs increased 3-fold compared with neck cells (Tuba1a; Table 1), 
Table 1
ZC-specific genes categorized under the GO term “microtubule”
Probe set Gene symbol Gene name Accession Fold change
10432404 Tuba1a Tubulin, alpha 1A NM_011653 2.98
10447224 Dync2li1 Dynein cytoplasmic 2 light intermediate chain 1 NM_172256 2.93
10520544 Mapre3 Microtubule-associated protein, RP/EB family, member 3 NM_133350 2.9
10518585 Kif1b Kinesin family member 1B NM_207682 2.48
10360479 Cep170 Centrosomal protein 170 NM_001099637 2.1
10387180 Ndel1 Nuclear distribution gene E-like homolog 1 (A. nidulans) NM_023668 1.92
10408610 Tubb2a Tubulin, beta 2a NM_009450 1.91
10359480 Dnm3 Dynamin 3 NM_001038619 1.8
10560491 Klc3 Kinesin light chain 3 NM_146182 1.76
10420320 Cenpj Centromere protein J NM_001014996 1.7
10411519 Mtap1b Microtubule-associated protein 1B NM_008634 1.67
10408975 Kif13a Kinesin family member 13A NM_010617 1.62
10572516 Mtap1s Microtubule-associated protein 1S NM_173013 1.55
10587368 Mto1 Mitochondrial translation optimization 1 homolog (S. cerevisiae) NM_026658 1.53
10533659 Clip1 CAP-GLY domain containing linker protein 1 NM_019765 1.5
10475293 Tubgcp4 Tubulin, gamma complex associated protein 4 NM_153387 1.49
10589541 Kif9 Kinesin family member 9 NM_010628 1.45
10398727 Klc1 Kinesin light chain 1 NM_001025360 1.45
10433721 Nde1 Nuclear distribution gene E homolog 1 (A. nidulans) NM_023317 1.45
10557233 Tnrc6a Trinucleotide repeat containing 6a NM_144925 1.45
10576056 Map1lc3b Microtubule-associated protein 1 light chain 3 beta NM_026160 1.44
10477353 Mapre1 Microtubule-associated protein, RP/EB family, member 1 NM_007896 1.44
10454655 Apc Adenomatosis polyposis coli NM_007462 1.41
10603567 Dynlt3 Dynein light chain Tctex-type 3 NM_025975 1.41
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which would be expected to lead to dramatic expansion of tubu-
lin mass, given the abundance of this ubiquitous cytoskeletal 
protein. Using immunofluorescence (IF) and confocal analyses, 
we confirmed the dramatic increase in the apical microtubular 
network relative to neck cells and how the elaborate microtubu-
lar expansion coordinated with movement of ZC nuclei toward 
the cell base (Figure 1, B and D).
Microtubules regulate cell shape and polarity and are the princi-
pal conduit for cellular vesicular trafficking (31–36); thus, we rea-
soned that the expansion of microtubules might also help coordi-
nate expansion of apical vesicular trafficking. Mature lysosomes, 
identified by expression of LAMP1, LAMP2, and cathepsin D, 
localized to the subnuclear basal compartment (R.U. Jin and J.C. 
Mills, unpublished observations), and early (i.e., EEA1-positive) 
Figure 2
The DAPK1-MIB1 protein complex is 
localized to the apical compartment of 
ZCs. (A) Fluorescent microscopy of an 
individual gastric unit (thick dashed out-
line) stained with GSII (red) and an anti-
body that specifically recognizes MAP1B 
phos phorylated at Thr1265 (green). 
Insets show pan-MAP1B expression 
(red) and the merged image of the 
base zone of the gastric unit (far right). 
(B and C) Gastric units were stained 
with GSII (red), DAPK1 (B; green) or 
MIB1 (C; green), and Hoechst (blue, 
nuclei; thin dashed outline). Enlarged 
views (×1.5-fold) of representative neck 
cell and ZC (solid outline) are shown in 
insets. DAPK1 (B) or MIB1 (C) immuno-
histo chemical staining (brown) is shown 
below. DAPK1 and MIB1 expression 
in the transition zone is indicated by 
arrowheads; lack of DAPK1 or MIB1 
expression in parietal cells is indicated 
by arrows. (D) Western blot of ubiquitin 
immuno precipitates for DAPK1. (E) Heat-
map representing expression values of 
DAPK1 and MIB1 probesets in neck 
cells and ZCs. Scale bars: 10 μm.
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endosomes showed no specific subcellular distribution (data not 
shown). We found a LAMP1-negative vesicular compartment, 
defined by expression of the cation-independent mannose-6-phos-
phate receptor (CI-M6PR) and by dramatic expansion of the pro-
protein convertase cathepsin L in the cell apex (Figure 1C). In cells 
with secretory granule stores, LAMP1-negative, and cathepsin L– 
and CI-M6PR–positive vesicles define a specific late endosomal 
and/or multivesicular body compartment involved in secretory 
granule maturation (37–41). This vesicular compartment was not 
detectable with these markers in neck cells (Figure 1C, insets) and 
parietal cells (Figure 1C, white arrows).
The stability and polarity of the microtubule network in ZCs 
are regulated by microtubule-associated proteins (MAPs) (32, 42). 
Additionally, microtubules in conjunction with MAPs facilitate 
spatial arrangements among the vesicular components of the 
secretory and endolysosomal pathways (33–35). We examined 
expression of 2 of the MAPS most increased during ZC matura-
tion, Mtap1b and Mtap1s (Table 1). MAP1B and MAP1S protein 
expression was specific for ZCs compared with neck cells and also 
was localized specifically to the apical compartment (Figure 1D 
and data not shown; results for MAP1B and for MAP1S were equiv-
alent). Collectively, these data showed that the dramatic expansion 
of the apical ZC compartment during maturation was correlated 
with elaboration of a microtubular network, specific trafficking 
of late endosomal vesicles and/or multivesicular bodies, and an 
increase in a microtubule coordinating protein, MAP1B, that is 
known to play a role in establishing polarized cell growth (43–45).
Apical localization of DAPK1 and apical expansion as a whole require 
MIB1. MAP regulation of microtubule dynamics in health and 
disease depends on regulated phosphorylation and dephosphory-
lation cycles (43, 44, 46). Using an antibody specific for MAP1B 
phosphorylated at Thr1265, an important functional phosphory-
lation site (43), we showed that much of the apical MAP1B in ZCs 
was phosphorylated (Figure 2A). Previous studies have shown that 
MAPs such as MAP1B are substrates for several serine/threonine 
kinases, including DAPK1 (43, 46–48).
The ability of DAPK1 to phosphorylate its downstream effec-
tors is strongly influenced by its location in the cytoplasm, which 
in turn is mediated by its direct interaction with the E3 ubiquitin 
ligase MIB1 (21, 22, 49). Both DAPK1 and MIB1 protein expres-
sion increased as ZCs began to leave the neck/base transition zone 
(Figure 2, B and C, arrowheads), and both localized apically, as con-
firmed by confocal microscopy. Neither DAPK1 nor MIB1 protein 
was detectable in parietal cells (Figure 2, B and C, arrows). Con-
sistent with previous data demonstrating MIB1-dependent ubiq-
uitination of DAPK1 (21, 22), IP of stomachs with anti-ubiquitin 
antibodies demonstrated that a pool of DAPK1 was indeed ubiq-
uitinated (Figure 2D). DAPK1 gene expression was maintained at 
significant levels in both neck cells and ZCs, but was unchanged 
between the 2 cell populations (mean Affymetrix expression val-
ues, neck cells, 66 ± 5; ZCs, 72 ± 4; Figure 2E), consistent with its 
known posttranscriptional regulation by MIB1 (21). In contrast, 
expression of MIB1 was substantially increased in ZCs versus neck 
cells (158 ± 5 vs. 53 ± 5; Figure 2E).
MIB1 regulates cell morphology, membrane trafficking (spe-
cifically late endosomal vesicles), and protein sorting (19, 50–52), 
although MIB1 function in the adult stomach has not been report-
ed. We hypothesized that the dramatic apical expansion of ZCs as 
they mature from neck cells could be governed at the molecular 
level by induction of MIB1 gene expression, which would cause 
apical localization and stabilization of DAPK1, in turn helping 
to coordinate apical vesicular trafficking and cytoskeletal expan-
sion via MAP1B. We therefore bred floxed Mib1 (Mib1Δ/Δ) mice (24) 
with Mist1CreER mice (53) to conditionally delete Mib1 in mature, 
MIST1-expressing ZCs. Induction of Cre recombinase caused 
loss of MIB1 in nearly all basal ZCs by 2 weeks (Figure 3A). Sub-
sequently, new wild-type ZCs, arising from mucous cell precursors 
migrating from the neck zone, slowly replaced Mib1Δ/Δ ZCs until 
none remained by 6 weeks (Figure 3 and data not shown). We used 
the 2-week time point for all subsequent experiments.
Consistent with our hypothesis that MIB1 regulates DAPK1 
localization in the apical cytoplasm of ZCs, Mib1Δ/Δ ZCs showed 
striking relocalization of DAPK1 from the supranuclear to the sub-
nuclear region of the cytoplasm (Figure 3B). As hypothesized, loss 
of apical localization caused loss of DAPK1 activity, as its substrate 
MAP1B was no longer detectable there in its phosphorylated form 
(Figure 3C). Loss of MIB1, apical DAPK1, and phosphorylated 
MAP1B all correlated with decreased apical trafficking of the CI-
M6PR/cathepsin L compartment that normally expanded during 
neck cell–to–ZC maturation (Figure 3, D and E). Furthermore, the 
activated form of cathepsin L was increased in Mib1Δ/Δ ZCs, indica-
tive of loss of the pro–cathepsin L form that normally traffics to 
the late endosomal compartment (37, 40). Finally, we observed 
that loss of MIB1 led to a dramatic accumulation of galectin 8, a 
marker of damaged endolysosomes (54), in the apex of Mib1Δ/Δ ZCs 
versus controls, whereas it was normally confined to the ZC bases, 
where autophagic/lysosomal activity was most prominent (Figure 
3F). These results were confirmed by confocal microscopy (data 
not shown). Overall, our findings indicated that MIB1 is required 
for the apical expansion of the cytoskeleton and normal vesicular 
trafficking that characterize ZC maturation.
Mib1Δ/Δ ZCs did not reexpress mucous neck cells markers such as 
GSII (Figure 3 and Supplemental Figure 2) or reenter the cell cycle 
(Supplemental Figure 2A), as occurs when ZCs become metaplastic 
(55). In addition, loss of MIB1 in ZCs did not affect cleavage of the 
Notch1 receptor in the mature gastric epithelium, which remained 
in the isthmal region (Supplemental Figure 2B), where Notch has 
been described to play a role in regulating proliferation of the stem/
progenitor cell (56). Loss of MIB1 also did not affect the protein 
expression level of Notch signaling intermediates Hes1 and Hes5 
in ZCs or in any other gastric cells, as determined by histology (data 
not shown). Hence, the effects of MIB1 loss were not likely the result 
of non–ZC-autonomous effects due to aberrant Notch signaling.
MIB1 is expressed in a MIST1-dependent fashion during ZC differen-
tiation. We next investigated the molecular regulation of Mib1 gene 
expression. Previous studies have determined a critical role for 
MIST1 in regulating neck cell–to–ZC maturation (4, 7, 15, 16, 57). 
To determine whether Mib1 expression is dependent upon MIST1 in 
the ZC lineage, gene expression profiles of neck cells and ZCs from 
Mist1−/− mice were prepared by LCM as described above. Whereas 
Mib1 and Mist1 transcripts were enriched concomitantly in ZCs com-
pared with neck cells in age-matched wild-type mice, Mib1 expres-
sion did not increase in Mist1−/− ZCs beyond the levels observed in 
neck cells (Figure 4A). These results were confirmed by PCR (data 
not shown). Similarly, MIB1 protein was detected only in transition 
cells just beginning to migrate out of the neck and into the base 
(Figure 4B, arrow), whereas mature Mist1−/− ZCs showed no detect-
able MIB1, and overall MIB1 protein levels were greatly reduced in 
Mist1−/− stomachs. Thus, loss of MIST1 reduced Mib1 expression, 
which suggests that MIB1 is a downstream target of MIST1.
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MIST1 regulates transcription of its target genes in part through 
its binding of a particular E-box, CATATG, frequently located 
within several kilobases of the end of the first exon (57, 58). Bio-
informatic scanning for conserved CATATG E-boxes showed dra-
matic multispecies conservation of a site within 1 kb of the first 
intron of the MIB1 gene (Figure 4C). We further confirmed MIB1 
as a direct MIST1 target via binding to the conserved E-box by per-
forming ChIP on the human gastric cancer cell line HGC-27 after 
transient transfection of a MIST1 expression plasmid (7). Prim-
ers flanking the conserved CATATG site generated amplicons in 
the MIST1-immunoprecipitated genomic fragments with greater 
efficacy than in preimmune control–precipitated DNA, whereas 
primers for control regions without a CATATG sequence within 
500 bp generated no amplicon (Figure 4C).
Along with ZCs, MIST1 is expressed during the terminal dif-
ferentiation of several highly specialized, high-capacity secretory 
cell lineages in mammals (59). MIB1 was expressed in a MIST1-
dependent fashion in pancreatic acinar cells, as shown by IF (Sup-
plemental Figure 3A), and the MIST1 binding site we detected 
in gastric cells was also detected in pancreatic ChIP sequencing 
experiments (S.F. Konieczny, unpublished observations, and 
ref. 60). Furthermore, gene array analysis of pancreas wild-type and 
Mist1–/– mice showed a dramatic decrease in MIB1 gene expression 
(60). Interestingly, MIB1 gene expression was rescued to wild-type 
levels in Mist1–/– pancreatic acinar cells upon forced expression of 
myc-tagged MIST1 (Supplemental Figure 3A). MIB1 expression 
was also induced as B cells matured into antibody-secreting plas-
ma cells and began to express MIST1 (Supplemental Figure 3B 
and ref. 61), and increased plasma cell MIB1 expression does not 
occur in Mist1−/− mice (59).
Apical compartment physiology is disrupted in the absence of MIST1. 
We next reasoned that, if MIST1 regulation of MIB1 is an impor-
tant aspect of ZC maturation, loss of MIST1 should cause an api-
cal compartment phenotype similar to that seen in the absence of 
MIB1. As in Mib1Δ/Δ ZCs, DAPK1 protein was mislocalized to the 
basal cytoplasm in Mist1-deficient ZCs (Figure 4D). IP from stom-
achs using anti-DAPK1 showed considerable association of DAPK1 
and MIB1, and the abundance of DAPK1 immunoprecipitatable by 
MIB1 was greatly decreased in the absence of MIST1 (Figure 4D). 
Thus, DAPK1 localization and its ability to interact with its subcel-
lular localizer MIB1 depended on MIST1. Other effects of the loss 
of MIB1 were also recapitulated by loss of MIST1: apical MAP1B 
was not phosphorylated in Mist1−/− ZCs, and CI-M6PR as well as 
cathepsin L vesicles were aberrantly trafficked (Figure 4, E and F).
We next sought to determine the potential physiological purpose 
of the MIST1-MIB1-DAPK1 control of ZC apical expansion. The 
primary purpose of ZCs is to store and secrete digestive enzymes 
in a regulated fashion. We reasoned that dysregulation of the 
vesicular compartment that has been shown to regulate secretory 
granule maturation would lead to disruption of ZC secretory gran-
ules. Consistent with that hypothesis, IF and Western blot analy-
ses showed that Mib1-null ZCs had dramatically reduced levels of 
2 proteins stored and secreted in their apical secretory granules: 
gastric intrinsic factor (GIF) and pepsinogen C (PGC) (Figure 5, 
A and B). Loss of MIB1 alone was sufficient to phenocopy the 
secretory granule loss characteristic of the Mist−/− ZC phenotype 
(16). Notably, MIB1-expressing transition cells unaffected by 
Mist1CreERT-mediated deletion of Mib1 showed abundant secretory 
granules filled with GIF and PGC (Figure 5, A and B), consistent 
with zymogenic secretory granule dependence on MIB1 and serv-
ing as an internal control highlighting the substantial depletion of 
granules in mature ZCs lacking MIB1.
To further characterize the defect in the granules in Mib1-null 
ZCs, we performed transmission electron microscopy (TEM). 
Mature zymogenic granules can be recognized by their relative 
electron density, which correlates with the increased packing of 
secretory contents. Consistent with previous reports (16, 62), wild-
type ZC granules were mostly mature, although occasional gran-
ules had a more electron-lucent immature phenotype (Figure 5C, 
arrowheads). In all Mib1Δ/Δ ZCs examined, all the secretory gran-
ules were electron lucent (Figure 5C), indicative of a substantial 
defect in secretory granule maturation in the absence of MIB1.
To test the physiological effects of MIB1-dependent apical 
vesicle trafficking in ZCs, the total enzymatic activity of pepsin 
from wild-type and Mib1Δ/Δ mice was determined using a modi-
fied hemoglobin proteolysis assay, first described in 1932 by 
Anson and Mirsky (63). The enzymatic activity of pepsin in whole 
stomach was significantly reduced in Mib1Δ/Δ mice (Figure 5D). 
The magnitude of reduction was within the range seen in previ-
ous reports of decreased pepsin activity in humans during gastric 
atrophy and progression to gastric cancer (64).
As described above, expansion of the apical compartment and 
the increase in digestive enzyme–secretory vesicles depended 
on migration of the nucleus to the basal cytoplasm of ZCs. In 
Mib1Δ/Δ ZCs, nuclear localization — as defined by the ratio of 
the distance from the nucleus to the apex (marked by the tight 
junction protein ZO-1) to the distance from the nucleus to the 
basement membrane (marked by the integrin CD49f) — was sig-
nificantly decreased compared with wild-type ZCs (1.2 ± 0.1 vs. 
6.5 ± 0.2, P < 0.0001; Figure 5E).
MIB1 expression is lost in mouse and human gastric SPEM. In both 
mice and humans, loss (atrophy) of parietal cells causes dramatic 
changes in ZCs (7, 9, 10, 15, 16). When parietal cells are killed with 
toxins like high doses of tamoxifen in mice, ZCs decrease expres-
sion of MIST1 as they undergo SPEM, which is characterized by 
reexpression of neck cell markers like GSII and TFF2 and, eventu-
Figure 3
MIB1 maintains apical compartment physiology by regulating the sub-
cellular localization of DAPK1. (A) Immunohistochemistry using anti-
MIB1 antibodies was performed on stomach sections from Mib1Δ/Δ and 
control (Ctrl) mice 2 weeks after initiation of tamoxifen treatment. Neck, 
transition, and base zones are indicated. PCR analysis of MIB1 tran-
script levels and Western blot analysis of MIB1 protein levels in Mib1Δ/Δ 
and control ZCs are also shown. (B) Fluorescent microscopy of individ-
ual gastric units (thick dashed outline) from Mib1Δ/Δ and control mice, 
2 weeks after tamoxifen treatment, stained for MIB1 (green; top) and 
with GSII and DAPK1 (red and green, respectively; bottom). Enlarged 
views (×1.5-fold) of representative ZCs (solid outline) are shown in 
the insets. Thin dashed outlines denote nuclei (Hoechst, blue). Note 
the basal subnuclear distribution of DAPK1 in Mib1Δ/Δ ZCs compared 
with the apical localization in control mice. (C) Gastric units stained for 
GSII (red) and phosphorylated MAP1B (green). (D and E) Gastric units 
stained for CI-M6PR (D; green) or for cathepsin L (E; green). Enlarged 
views (×1.5-fold) of representative ZCs are shown in the insets. West-
ern blot for pro–cathepsin L and activated cathepsin L is also shown in 
E. (F) Gastric units stained for galectin 8 (green; top) and with galec-
tin 8 and GIF (green and red, respectively; bottom). Enlarged views 
(×1.5-fold) of representative ZCs are shown in the insets. Note the 
accumulation of galectin 8 in the apical compartment of Mib1Δ/Δ ZCs. 
Scale bars: 10 μm (C–F); 20 μm (B); 40 μm (A).
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ally, reentry into the cell cycle (65). In humans showing features of 
early SPEM, there is loss of MIST1 and equivalent cellular changes 
(15). We reasoned that loss of MIST1 would lead to loss of MIB1, 
which might affect the ZC apical secretory apparatus. Thus, we 
induced SPEM by killing parietal cells with 3 consecutive injec-
tions of high-dose tamoxifen (5 mg/20 g BW; Figure 6A and ref. 
65). Figure 6B depicts the expression of MIST1, MIB1, and gastric 
epithelial cell lineage markers relative to onset and recovery from 
metaplasia in this system. Vehicle-treated mice showed normal 
development patterns of neck cells (GSII, red stain) to ZCs, with 
expression of MIST1 (green nuclear stain; white arrows) and MIB1 
(green cytoplasmic stain) restricted to the ZCs in the base of the 
gastric unit, where levels of digestive enzymes (PGC, purple stain) 
were highest. In contrast, by the last day of toxic-dose tamoxifen 
treatment (i.e., day 3), expression of the neck cell marker GSII was 
detected in ZCs (pathognomonic for SPEM onset, which is defined 
by reexpression of neck cell markers like TFF2 and GSII in ZCs; 
ref. 15), while MIST1 levels were mostly undetectable (Figure 6A).
Metaplastic glands at this time point showed a mosaic pat-
tern of MIB1 expression: each cell had MIB1 levels that corre-
lated positively with expression of the digestive enzyme PGC and 
negatively with the neck cell marker GSII on a per-cell basis. The 
photomicrograph in Figure 6C is representative of the pattern we 
quantified by digitizing MFI in cytoplasms of all basal cells of the 
neck cell–ZC lineage. Next, we binned cells according to degree of 
MIB1 staining: cells ≥70% of maximal normalized MFI in a field 
were scored as 2, those ≤ 30% of maximal MFI were scored as 0, 
and the midrange cells received a score of 1. Quantification of 
individual cells in the base with differing levels of MIB1 (n = 50 
cells) showed that cells with high MIB1 expression had the high-
est levels of PGC and almost no GSII (Figure 6C). Detectable 
GSII occurred only in cells with lower MIB1 expression, which 
also correlated with decreased PGC. We interpret cells with this 
intermediate MIB1 immunostaining to be hybrid cells, transi-
tioning into SPEM. Cells with near-baseline MIB1 had low but 
detectable levels of PGC and showed high levels of GSII, consis-
tent with a full SPEM phenotype. Cells at day 3 that, like normal 
MIB1-expressing ZCs, were not yet reexpressing the epitope for 
GSII also maintained DAPK1 and had phosphorylated MAP1B 
(Supplemental Figure 4). 
Thus, MIB1 expression began to decrease during onset of meta-
plasia, consistent with its regulation by MIST1, which is also lost 
with metaplasia (15). By 7 days, gastric units had undergone com-
plete metaplastic transformation, as indicated by the presence of 
GSII labeling throughout the base zone, a complete loss of MIST1, 
and a 78% reduction in PGC levels (Figure 6B). MIB1 expression 
was entirely lost in the metaplastic ZCs at this time point. As 
expected, DAPK1 could be found only in the basal portion of the 
metaplastic ZCs, and phosphorylation of MAP1B was abrogated 
(Supplemental Figure 4). In this metaplasia model, there is com-
plete recovery of gastric unit differentiation within 2–3 weeks (65). 
Accordingly, mice at 21 days after treatment displayed recovery in 
the cellular and molecular architecture of the base (Figure 6B). 
During recovery, those cells with normal morphology, including 
expanded apical compartments with normal DAPK1 localization 
and MAP1B phosphorylation, showed reexpression of both MIST1 
and MIB1, which suggests that reexpression is concomitant with 
recovery of the ZC lineage.
Tamoxifen-induced SPEM mimics Helicobacter pylori–induced 
SPEM; accordingly, we analyzed the base of gastric corpus units in 
5 mice infected with a CagA+ strain of Helicobacter PMSS1 8 weeks 
after infection. Treatment caused parietal cell atrophy and SPEM 
in multiple regions throughout most of the corpus. Supplemen-
tal Figure 5 shows a representative region in which a few residual 
normal units with MIB1-positive ZCs were preserved; note that 
those cells did not show labeling with GSII, whereas other gastric 
units throughout the corpus showed SPEM with GSII-labeled, 
MIB1-negative cells.
Our analysis of the time course and progression of SPEM in mice 
indicated that cells transitioning to SPEM progress first through 
a stage equivalent to that seen in our Mib1Δ/Δ mice, in which 
MIB1 is lost, and loss of the secretory vesicle apparatus leads to 
decreased storage of cytoplasmic PGC, but markers of neck cells 
are not expressed. Note that in Figure 6C, only cells without MIB1 
(“0” cells) showed GSII, and those cells had diffuse, reduced PGC, 
whereas transitional cells with reduced MIB1 (“1” cells) main-
tained PGC without GSII, which suggests that MIB1 levels must 
drop below a critical level before the apparatus for high-capacity 
secretory vesicle packaging is dismantled. Expression of high levels 
of MIB1 was nearly exclusive of detectable GSII, which suggests 
that reduced MIB1 and loss of apical secretory architecture nor-
mally occur before reexpression of mucous neck cell markers in 
ZCs, the pattern diagnostic of SPEM.
Parietal cell atrophy in humans also correlates with loss of 
MIST1 in ZCs. Thus, we next sought to determine whether loss 
of MIB1 and downscaling of large apical PGC granules also rep-
resented a heretofore-undiscovered initial phase of SPEM in 
humans. We analyzed a series of 62 routine gastric biopsies and 
resections (Table 2) from multiple institutions in 2 different 
nations (15). Using MIB1 and GSII labeling, we identified those 
specimens with regions characterized by “hybrid,” or early, SPEM 
with low to absent MIB1 and moderate GSII; Figure 7A shows a 
representative field from 1 such specimen. This specimen also 
showed a region with normal neck cell–to–ZC differentiation 
(Figure 7A, white arrows), demonstrating that in humans, as in 
mice, levels of MIB1 increased apically as ZCs migrated toward 
the base of the gastric unit. A region of mature SPEM, with high 
basal GSII and no MIB1, was also observed (Figure 7A, yellow 
Figure 4
MIST1 regulates MIB1 expression during ZC differentiation. (A) Micro-
array analysis of Mist1 and Mib1 gene expression from isolated popula-
tions of neck cells and ZCs from wild-type and Mist1–/– mice. (B) Mist1–/– 
gastric unit (thick dashed outline) stained for GSII (red) and MIB1 
(green). MIB1 was expressed in the transition zone (white arrow). West-
ern blot of MIB1 protein levels in wild-type and Mist1–/– whole stomach 
corpus is also shown. (C) The human MIB1 gene, represented to scale, 
with numbered exons as vertical lines. Note the dramatic conservation 
of the CATATG sequence, located within the first 1 kb of the end of 
the first exon, across multiple mammalian species. Also shown are gel 
electrophoresis images of PCR amplicons from ChIP experiments using 
anti-MIST1 antibody in HGC-27 cells followed by primers as indicated 
(see Methods). (D) Mist1–/– gastric unit stained for GSII (red) and DAPK1 
(green). Thin dashed outlines denote nuclei (Hoechst, blue). Enlarged 
view (×1.5-fold) of a representative ZC (solid outline) is shown in the 
inset. Western blotting of MIB1 immunoprecipitates from wild-type and 
Mist1–/– mice for DAPK1 is also shown. (E) Mist1–/– gastric unit stained 
for GSII (red) and phosphorylated MAP1B (green). (F) Mist1–/– gastric 
unit stained for GSII (red) and for CI-M6PR (green; top) or cathepsin L 
(green; bottom). Enlarged views (×1.5-fold) of representative ZCs are 
shown in the insets. Scale bars: 10 μm (E and F); 20 μm (B and D).
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Figure 5
Disruption of apical compartment physiology in ZCs decreases the levels and enzymatic activity of digestive enzymes. (A) Fluorescent micros-
copy of individual gastric units (dashed outline) from Mib1Δ/Δ and control mice 2 weeks after tamoxifen treatment stained for MIB1 and GIF (green 
and red, respectively; top) or with GIF alone (red; bottom). Note that GIF accumulated only in the cells migrating from the neck zone with a full 
complement of MIB1. (B) Gastric units from Mib1Δ/Δ and control mice 2 weeks after tamoxifen treatment stained for PGC (red). Note the accumula-
tion only in Mib1Δ/Δ transition cells. (C) TEM images of individual ZCs from Mib1Δ/Δ and control mice and higher-magnification views of secretory 
granules (insets). Scatter plots of electron density of each granule from 3 different cells per genotype are also shown. Each data point represents 
an individual granule within that cell. (D) Quantification of pepsin activity in wild-type and Mib1Δ/Δ mice relative to pepsin activity in Mist1–/– mice 
showed nearly abrogated storage of pepsinogen granules in mature ZCs. (E) Gastric ZCs stained for ZO-1 (green) and integrin CD49f (red). Cells 
are shown en face to demonstrate that cell height was consistent and parallel to cell base. Graphical representation of the ratio of the distance 
from nucleus to luminal apex to the distance between nucleus and cytoplasm for each group (n = 50 cells) is also shown. Scale bars: 500 nm (C, 
insets); 2 μm (E); 10 μm (C); 20 μm (A and B). Data represent mean ± SEM. **P < 0.01; ***P < 0.0001.
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outline). We analyzed all 18 specimens that had SPEM using the 
same MIB1 binning system we developed in mice. Regions of 
hybrid SPEM were relatively common, as 1 in 5 basal glands with 
SPEM had some features of hybrid SPEM (i.e., detectable MIB1 
and low to absent GSII; Figure 7, A–C). Quantification of these 
regions showed that in humans, as in mice, cells with high lev-
els of MIB1 (expression score 2) also expressed high levels of PGC 
while maintaining near-undetectable levels of GSII, and cells with 
low MIB1 levels (expression score 0) had decreased PGC stores and 
fully reexpressed the epitope for GSII (Figure 7D), indicative of 
SPEM. Figure 7C depicts a representative confocal image where 
transitional phenotypes could be seen in adjacent cells, highlight-
ing transitional phenotypes between normal ZCs and SPEM in an 
individual unit. Note that wherever there was residual MIB1 (“2” 
cell, white outline), PGC expression was stronger and packaged 
into large apical secretory vesicles; where MIB1 was undetectable, 
PGC was diffuse, in smaller vesicles, or nearly undetectable (“0” 
cell, yellow outline). Overall, the results indicated that in humans, 
as in mice, substantially decreased expression of MIB1 (presum-
ably secondary to loss of MIST1) represents the first detectable 
morphological change in cells transitioning to SPEM, occurring 
before reexpression of mucous neck cell markers.
SPEM often occurs with the other predominate type of metapla-
sia induced by parietal cell death, intestinal metaplasia, which is 
characterized by ectopic formation of intestinal epithelium (goblet 
cells and brush border–expressing enterocytes) and expression of 
the transcription factor CDX2 (15). Of the specimens we exam-
ined, 26 showed characteristics of intestinal metaplasia. MIB1 
expression in these lesions was consistently low to moderate 
(expression score 1), but not absent (data not shown).
Given that MIB1 expression appeared to be the earliest change 
in ZCs after parietal cell atrophy and that gastric cancer in general 
occurs only in the setting of such atrophic/metaplastic changes, we 
hypothesized that MIB1 would not be expressed in gastric adenocar-
cinoma. We examined a limited cohort of 15 dysplastic and carcino-
matous lesions for MIB1 expression (Table 2). There was no detect-
able expression of MIB1 in the dysplastic lesions, regardless of grade 
of dysplasia (Supplemental Figure 6A). We noted focal expression 
of MIB1 in 4 of 5 adenocarcinomas exhibiting signet ring morphol-
ogy (Supplemental Figure 6B). The invasive adenocarcinomas with 
intestinal differentiation in the cohort we immunostained were uni-
formly MIB1 negative (Supplemental Figure 6C).
Discussion
Here, we addressed the central question of how the temporal reg-
ulation of a single gene can control specific subcellular morphol-
ogy and function in a polarized epithelium. We present evidence 
that many aspects of the apical secretory compartment expan-
sion that occurs in gastric ZCs are regulated at the transcription-
al level by MIST1-dependent maintenance of a specific cellular 
effector, MIB1. Our data showed that MIB1 and DAPK1 formed a 
molecular complex in the apical membrane compartment during 
ZC maturation. Conditional knockout of Mib1 in ZCs revealed 
that MIB1 was necessary for the apical localization of DAPK1. 
Mislocalization of DAPK1 to the basal cytoplasm caused loss 
of MAP1B phosphorylation and a significant defect in apical 
membrane trafficking and secretory granules. Collectively, these 
data suggest that MIB1 and DAPK1 operate as part of a signal-
ing complex that directs the changes in apical cell structure, 
polarization, and endolysosomal vesicle compartmentalization 
as neck cells transform into ZCs. Ultimately, all of this coordina-
tion of apical protein events depended on MIST1’s regulation of 
MIB1 at the transcriptional level.
The expansion and maturation of the apical compartment 
appear to be critical for secretory cell function, as loss of MIST1 
and/or MIB1 caused profound maturation defects in secretory 
granules. Within the ZC apical cytoplasm, secretory proteins are 
being packaged in secretory granules for delivery to the luminal 
apex. Vesicles containing lysosomal hydrolases and proprotein 
convertases are sorted and trafficked to lysosomes in the basal 
cytoplasm to multivesicular or recycling endosomes as part of sig-
naling networks and in and out of the secretory granules them-
selves, a process that is key to the maturation/processing of their 
cargo (66–69). Microtubules are the principal conduit for cellular 
vesicular trafficking (33, 34), and ZCs construct an elaborate net-
work of microtubules in the apical membrane compartment. We 
demonstrated that the segregation of these vesicle compartments 
on microtubules was regulated, in part, by a signal transduction 
pathway that involved the phosphorylation of MAP1B by DAPK1 
that was maintained by MIB1. MAP1B is a key target of DAPK1 
(46). DAPK1 also plays a key role in the regulation of cell mor-
phology by bridging membrane proteins with the cytoskeleton 
(46, 70–72). Finally, unbiased loss-of-function studies have shown 
that DAPK1 is required specifically for proper subcellular localiza-
tion of late/recycling endosomes (72), the vesicular compartment 
expanded in the apex of maturing ZCs, as described above. These 
molecular events are necessary for ZCs to maintain their mature 
phenotype and, subsequently, their loss leads to a deficiency in 
mature (i.e., digestive enzyme–packed) secretory granules.
Expression of Mib1 is significantly increased as neck cells transi-
tion to ZCs. 2 principal mechanisms have been described for MIB1 
function: activation of Notch signaling though the ubiquitination 
and endocytosis of the Notch ligands Delta and Jagged (19, 24), 
and regulation of DAPK1 during apoptosis (21, 22). There is no 
documented role for Notch in ZC homeostasis, and we observed 
no changes in Notch-regulated genes during neck cell–to–ZC tran-
sition or in the absence of MIST1/MIB1. Rather, consistent with 
previously published data (56), we detected Notch pathway activity 
only in the isthmal region, where the corpus stem cell resides; this 
localization did not change when MIB1 was lost in ZCs (56). More-
over, the same study showed that there was no effect on the ZC lin-
eage, or parietal cell lineage, in adult mice treated with the known 
Notch antagonist dibenzazepine (56). On the other hand, we here 
demonstrated in gastric ZCs: (a) a direct interaction between MIB1 
and DAPK1; (b) that DAPK1 was ubiquitinated and ubiquitination 
was attenuated in the absence of MIB1; and (c) that apical localiza-
tion of DAPK1 also depended on MIB1. Our studies are the first to 
demonstrate that MIB1 functions upstream of DAPK1 to regulate 
a subcellular compartment in mature, fully differentiated cells.
MIB1 target specificity and, thus, its molecular function may 
vary at different points in development. Indeed, recent studies 
have indicated that MIB1 can regulate morphogenesis of postmi-
totic neurons by interacting with proteins involved in the mainte-
nance of secretory vesicle transport, cytoskeletal rearrangement, 
and cell adhesion (51). Collectively, these data suggest that MIB1 
can function on 2 levels: during cell fate specification, and dur-
ing maturation of terminally differentiated cells. Our current 
data highlight the importance of MIB1 in maintaining cell matu-
ration. After we induced loss of Mib1 expression in mature ZCs, 
MIB1 protein expression was consequently lost, its target proteins 
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Figure 6
MIB1 expression is lost during the progression of mouse SPEM. (A) 
Experimental design. (B) Representative immunostain of mice treated 
with vehicle or high-dose tamoxifen (5 mg/20 g BW). Top panels were 
stained with GSII (red), MIB1 (green, cytoplasmic), MIST1 (green, 
nuclear), and Hoechst (nuclei, blue). Bottom panels were stained 
with PGC (purple) and Hoechst (blue, nuclei). Arrows indicate nuclear 
MIST1 staining. Graphical representation of MFI for MIB1 (green), GSII 
(red), and PGC (purple) in the basal cells of ZC lineage over time is 
also shown. (C) Representative immunostain of hybrid SPEM lesion 
at day 3 after tamoxifen treatment stained with MIB1 (green; top), GSII 
(red; middle), and PGC (purple; bottom). Individual cells (outlines) were 
assigned a MIB1 expression score: 2, high; 1, intermediate; 0, low. 
Graphical representation of the correlation of MIB1 expression score 
and MFI for PGC and GSII in individual cells is also shown. Scale bars: 
5 μm (C); 20 μm (B). Data represent mean ± SD.
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phological patterns: namely, MIB1 and GSII were mutually exclu-
sive, and MIB1 expression was highly positively correlated with 
normal apical PGC granular content.
We speculate that dismantling of the apical secretory appara-
tus, which could be identified by loss of MIB1 labeling in ZCs, is 
a distinct step in metaplasia that occurs before the changes cur-
rently used to diagnose appearance of SPEM (i.e., reexpression of 
neck cell markers). Given that loss of MIB1 alone in Mib1Δ/Δ ZCs 
was sufficient to induce a morphology similar to this initial stage 
of metaplasia, with disrupted apical secretory granule packaging, 
and that loss of MIST1 caused loss of Mib1, we propose that loss of 
MIST1 expression is the initial molecular event that induces this 
first step in transition to metaplasia. Loss of MIB1 alone, how-
ever, was not sufficient to cause neck cell marker expression in 
ZCs. Thus, other mechanisms independent of MIB1 must induce 
expression of neck cell genes, which does not seem surprising, 
as it would not be obvious how MIB1 regulating apical cytoskel-
etal and trafficking machinery might affect transcription and/
or translation. Although loss of MIB1 is apparently sufficient for 
the initial phase of SPEM, it is not clear whether MIB1 must be 
lost for the next phase of SPEM to occur, which is a clear avenue 
for future study. Dedifferentiation of MIST1-expressing cells also 
occurs during acinar-to-ductal metaplasia in the pancreas, which 
has been called the initiating event for ductal adenocarcinomas in 
that organ (53, 60, 74). It is interesting to speculate whether loss 
of MIB1-dependent apical secretory differentiation in those cells 
also occurs prior to the reexpression of ductal markers in a man-
ner that parallels loss of MIB1 prior to reexpression of neck cell 
markers in the stomach.
Together, our results indicate a key regulatory mechanism 
involved both in the normal scaling up of a specific subcellular 
compartment required for normal physiology of exocrine secre-
tory cells and in the scaling down of that same compartment in 
those same cells during pathophysiological changes. This mecha-
nism may be conserved in a cross-species, cross-tissue fashion, pro-
viding a tool for understanding how cells in diverse environments 
derive their form and function throughout development.
Methods
Mice. Germline Mist−/− mice (75) were maintained in a specific pathogen–
free barrier facility. Mist1CreERT mice were generated as previously described 
(53) and bred to Mib1fl/fl mice (24). Mist1CreERT/+Mib1fl/fl mice were generated 
and at 6 weeks of age were given 5 consecutive intraperitoneal injections of 
tamoxifen (1 mg/20 g BW; Sigma-Aldrich). Deletion of Mib1 did not lead 
to immediate death of ZCs, as there was no substantial difference in ZC 
census or apoptosis levels between control mice (i.e., tamoxifen-treated ani-
mals not expressing Mist1CreERT) and induced Mib1-null mice. Control mice 
were Mist1CreERT/+Mib1fl/fl mice treated with tamoxifen vehicle only or were 
tamoxifen-treated littermates of Mist1CreERT/+Mib1fl/fl mice that lacked either 
the Cre allele (Mist1+/+Mib1fl/fl) or both flox inserts (Mist1CreERT/+Mib1+/+).
Patient samples. Serial sections (4–6 μm thick) obtained from paraffin-
embedded tissue samples (H&E and alcian blue–periodic acid–Schiff 
stains) were reviewed by 2 pathologists with specific expertise in gastroin-
testinal diseases, and a consensus on the score for each pertinent histologic 
variable was reached. Diagnoses and selection of specific regions of transi-
tion among normal stomach, atrophic stomach, and intestinal metaplasia 
was performed by a third pathologist.
IF/cell imaging. Stomachs were prepared and stained as described previ-
ously (16). Briefly, stomachs were inflated with freshly prepared methacarn 
fixative and suspended in fixative for 15–30 minutes at room temperature, 
began to accumulate in the wrong compartment, and cell function 
was abrogated. Thus, Mib1 expression is necessary throughout the 
lifespan of the mature secretory cell.
The mechanisms that control Mib1 expression had not previ-
ously been reported. Here, we revealed that Mib1 is a direct tran-
scriptional target of MIST1. MIST1 is a developmentally regulated 
transcription factor that does not specify cell fate, but rather regu-
lates the development of secretory cell structure and function (1). 
Our data suggest that MIST1 regulation of Mib1 may be generally 
conserved, as we have identified multiple secretory cell lineages of 
diverse origin — plasma cells (59) as well as gastric ZCs and pancre-
atic acinar cells (present study) — in which MIST1 is able to scale 
the levels of Mib1 transcription. While the scaling of Mib1 expres-
sion in stomach is regulated by MIST1, our data suggest that its 
transcription is initiated upstream of MIST1, possibly by another 
lineage-specific transcription factor, because expression of MIB1 
in cells transitioning between the neck and base was maintained 
even in the absence of MIST1.
Stomach cancer is the fourth most common and second most 
fatal malignancy worldwide; however, our understanding of 
the molecular and morphological progressions that cause this 
malignancy is limited (12–14). During SPEM-type metaplasia in 
the stomach, ZCs reexpress markers of their progenitor mucous 
neck cell phase and reenter the cell cycle, increasing the risk for 
subsequent dysplasia and carcinoma by mechanisms that remain 
poorly understood (15, 73). Such changes in cell morphology are 
common in carcinogenesis and an area of active research (7, 9, 15, 
53). We have previously shown that MIST1 expression is almost 
universally lost in all gastric carcinomas (15).
Our present data allow us to speculate about the molecular 
mechanisms underlying the transition of ZCs into SPEM cells. 
Using doses of tamoxifen that induce near-synchronous death of 
parietal cells, we followed the sequential response of ZCs, which 
began to lose MIB1 expression within 3 days. Concomitant with 
or slightly after the loss of MIB1, there was loss of densely packed 
apical secretory granules, as evidenced by dispersal of PGC immu-
nolabeling from large, densely packed granules. Reexpression of 
the neck cell marker GSII was almost never seen in cells express-
ing detectable MIB1, which indicates that loss of MIB1 and dis-
mantling of the apical secretory apparatus occur before neck cell 
marker reexpression. In mice infected with H. pylori and in mul-
tiple human stomach specimens, in regions transitional between 
complete SPEM and normal morphology, we saw the same mor-
Table 2
Summary of MIB1 expression in patient samples
 Total Predominant MIB1 
 incidence expression score
  0 1 2
Normal 11 0 0 11
SPEMA 18 18 0 0
Intestinal metaplasia 26 0 26 0
Dysplasia 4 4 0 0
Cancer (diffuse type) 5 1 4 0
Cancer (intestinal adenocarcinoma) 5 5 0 0
n = 28 (Nicaragua); 34 (United States). AExcludes regions of hybrid 
SPEM analyzed in Figure 7.
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5 minutes in 1 μg/ml bisbenzimide (Invitrogen) prior to mounting in 1:1 
glycerol-PBS. Fluorescence microscopy and imaging were performed using 
a Zeiss Axiovert 200 microscope with ×20 (Plan-Apochromat, 0.811 NA), 
×40 (Plan-Neofluar, 0.85 NA), and ×63 (Plan-Apochromat, 1.4 NA) objec-
tives with an Axiocam MRM camera and AxioVision software. Additional 
confocal microscopy and imaging were performed using a Zeiss LSM510 
followed by multiple rinses in 70% ethyl alcohol (EtOH), arrangement 
in 2% agar in a tissue cassette, and routine paraffin processing. Sections 
(5 μm) were deparaffinized and rehydrated, and then antigen retrieval 
was performed by boiling in 50 mM Tris-HCl, pH 9.0. Slides were blocked 
in 1% BSA and 0.3% Triton X-100 in PBS and then incubated in primary 
antibodies followed by secondary antibodies. Slides were incubated for 
Figure 7
MIB1 in human metaplasia and cancer. (A) Unitary variation of MIB1 (green) and GSII (red), presenting as normal pattern, hybrid SPEM, and 
complete SPEM, as indicated. Normal gastric mucosa showed MIB1-positive ZCs (arrows). The hybrid SPEM region showed decreased levels 
of MIB1 and coexpression of GSII in the base of the gland (arrowheads). In contrast, MIB1 expression was completely lost in fully transformed 
SPEM (yellow outline). (B and C) Representative immunostain (B) and confocal imaging (C) of a hybrid SPEM lesion stained for MIB1 (green), 
GSII (red), PGC (purple), and Hoechst (blue, nuclei). Cells with MIB1 expression scores of 0 (yellow outline), 1 (gray outline), and 2 (white outline) 
are indicated. (D) Graphical representation of the correlation of MIB1 expression score and PGC and GSII expression (MFI) in individual cells. 
Data represent mean ± SD. Scale bars: 1 μm (C); 10 μm (B; A, insets); 50 μm (A). 
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cell lineage relative to the other lineages, according to the following param-
eters: lower bound of 90% confidence, fold change ≥1.2; expression inten-
sity difference, ≥50. Parietal cell–specific genes were derived from LCM 
experiments previously performed (16), and those genes were removed 
from the list of ZC-specific genes. Gene chips are available through GEO 
(accession no. GSE43441).
Conversion of cell-specific gene lists into GO distributions. Lists of cell type– 
specific genes for each gastric epithelial cell lineage were associated with 
GO terms using GOurmet Vocabulary software (29). Among those GO 
terms, those associated with specific subcellular domains or processes were 
identified and depicted in Figure 1, Table 1, and Supplemental Figure 1.
Analysis of MIB1 gene cis-regulatory elements. The ECR browser (78) was used 
to analyze the human genomic sequence for MIB1 5′ to the transcription 
start. Sequence was analyzed up to 50 kb or until an exon from the neigh-
boring gene was reached. The first intron up to 50 kb was also analyzed. 
CATATG sequences within analyzed sequences were identified using the 
dreg application in the EMBOSS suite. Conservation among species aligned 
in the ECR browser was then determined at each of these CATATG sites.
ChIP. ChIP was performed as previously described (57). Approximately 
108 HGC-27 cells transfected with a MIST1 expression plasmid were har-
vested for 1 ChIP experiment. 15 μl of MIST1 antiserum (rabbit polyclonal 
anti-human MIST1) or serum from the rabbit prior to immunization 
(preimmune control) together with protein A/G plus agarose (Santa 
Cruz Biotechnology) was added to the cell lysate for IP. Regular PCR and 
qRT-PCR were performed to assess the quantity of genomic sequences 
immunoprecipitated by either preimmune control or MIST1 antise-
rum, as well as a 1:10 dilution of the cell extract prior to IP. The follow-
ing primers were used to assess IP of binding sites: MIST1 conserved site 
forward, CGACTCCTCCTCTTGGGAAG; MIST1 conserved site reverse, 
CATCTCCACAAATCCGAGGT; control site forward, GCAGGATAGC-
CAACCTTCAT; control site reverse, TATTATAGTCCTGGGGCAAAACA. 
Western blot, qRT-PCR, and co-IP from stomach tissue. For blots, corpus 
tissue was homogenized in RIPA buffer using a PowerGen 700 (Fischer 
Scientific) with proteins separated on NuPAGE 4%–12% (Invitrogen), 
transferred to polyvinylidene difluoride, and detected by Immobilon che-
miluminescence (Millipore). Primary antibodies were rabbit anti-MIB1 
(1:1,000), rabbit anti-DAPK1 (1:1,000), goat anti-GIF (1:20,000), and goat 
anti-actin (1:1,000; Santa Cruz Biotechnology). Secondary antibodies were 
horseradish peroxidase–conjugated donkey anti-rabbit (1:2,000; Jackson 
ImmunoResearch) and donkey anti-goat (1:2,000; Santa Cruz Biotechnol-
ogy). For qRT-PCR, total RNAs from corpus were extracted and assayed as 
described previously (79). Co-IP was performed using a Pierce Crosslink 
IP Kit (Thermo Scientific) with anti-MIB1 antibodies (Sigma-Aldrich) or 
anti-ubiquitin antibodies (Santa Cruz Biotechnology).
TEM. For TEM studies, stomachs were fixed, sectioned, stained, and 
imaged as previously described (16). Scoring of electron density was per-
formed using Image J.
Statistics. All graphs and statistics were determined with GraphPad Prism 
and then visualized using Adobe Illustrator. Statistical analysis was by 
2-tailed Student’s t test. A P value of 0.05 or less was considered significant.
Study approval. All experiments involving animals were performed 
according to protocols approved by the Washington University School of 
Medicine Animal Studies Committee. Acquisition of human gastric path-
ological tissue specimens was approved by the Institutional Review Board 
of Washington University School of Medicine, the Comité de Bioetica of 
Nicaragua for Universidad Nacional Autonoma De Nicaragua — Facultad 
De Ceincias Medicas Managua, and the Research Ethics Board Manager 
for Health Sciences at the University of Toronto. Either patients provided 
informed consent prior to their participation, or, in some cases, tissue 
was from archived specimens taken for diagnosis, so informed consent 
META microscope with ×40 (EC Plan-Neofluar, 0.7516 NA) and ×63 (Plan-
Apochromat, 1.4 NA) objectives using LSM510 software.
To visualize microtubules, stomachs were flushed with PBS at 37°C, fol-
lowed by 2% paraformaldehyde, 75 mM lysine, 25 mM taxol, 0.1% Triton 
X-100 in PBS. Sections were fixed for 20 minutes at 37°C followed by a 
wash with 5% sucrose in PBS at 37°C and embedded in OCT. 5-μm-thick 
sections were cut, rehydrated in PBS, and incubated with Alexa Fluor 488–
conjugated anti–α-tubulin antibody (eBioscience).
The following primary antibodies were used for immunostaining: goat 
anti-human GIF (1:2,000; gift of D. Alpers, Washington University School 
of Medicine); sheep anti-PGC (1:10,000; Abcam); mouse anti–α-tubulin 
(1:500; Sigma-Aldrich); phalloidin; myosin; integrin; mouse anti–cathep-
sin L (1:100; Novus Biologicals); rabbit anti–CI-M6PR (1:500; gift of 
S. Kornfeld, Washington University School of Medicine); mouse anti-
MAP1B (1:100; Sigma-Aldrich); rabbit anti–phosphorylated MAP1B 
(1:200; Novus Biologicals); rabbit anti-DAPK1 (1:200; Sigma-Aldrich); 
rabbit anti-MIB1 (1:500; Sigma-Aldrich); mouse anti–galectin 8 (1:100; 
Sigma-Aldrich); rabbit anti-MIST1 (1:200; ref. 15). Secondary antibodies 
used were Alexa Fluor 488–, 594–, and 647–conjugated donkey anti-goat, 
anti-rabbit, anti-sheep, and anti-mouse antibodies (1:500; Invitrogen).
IF quantification to determine cytoplasmic MFI was performed with 
NIH ImageJ software. MFI was determined in each cell after subtraction of 
background, which was determined by averaging the fluorescence signal 
in 5 parietal cells, which did not express any lineage marker examined, 
from the same gastric unit.
Apical cytoplasm measurements were performed using Image J software.
LCM and quantitative real-time PCR (qRT-PCR). Preparation of stom-
ach frozen sections for LCM has been described previously (16). Briefly, 
stomachs were excised immediately after sacrifice, quickly flushed with 
room-temperature PBS, inflated by duodenal injection of OCT compound 
(Sakura Finetek), frozen in Cytocool II (Richard-Allen Scientific), and cut 
into serial 7-μm-thick cryosections, which were mounted on Superfrost 
slides (Fisher Scientific), fixed in 70% EtOH, rehydrated in nuclease-free 
water (nuclease-free solutions from Ambion), and then incubated in Alexa 
Fluor 488–conjugated Griffonia simplicifolia GSII (diluted 1:500 in nuclease-
free water) for 15 minutes. Sections were washed in nuclease-free water 
and dehydrated in graded ethanol followed by xylene. ZCs were identified 
as corpus cells that were basal to GSII labeling and did not show the dark 
silhouettes and characteristic shape of parietal cells after xylene dehydra-
tion. 4 wild-type mice and 5 Mist1−/− mice were used for dissection (Pix-
Cell II LCM apparatus [7.5-μm spot diameter] and CapSure HS LCM caps; 
Arcturus) to generate 2 caps per mouse. RNA was purified by PicoPure 
kit (Arcturus), and RNA integrity was confirmed by an Agilent 2100 Bio-
analyzer. qRT-PCR was performed only on RNA that had sharp 18S and 
28S bands. All RNA from each cap was treated with DNase I (Invitrogen) 
and then reverse transcribed using the SuperScript III (Invitrogen) stan-
dard protocol (most cDNA syntheses started with 10 ng total RNA). Mea-
surement of cDNA levels was performed by qRT-PCR using a Stratagene 
MX3000P detection system, and Absolute QPCR SYBR green mix (Thermo 
Scientific) fluorescence was used to quantify relative amplicon amounts 
of mouse Mib1, Mist1, and 18S rRNA, with the following primers: Mib1 
forward, GTCATCCCAGTCTCCAGGATTCTGAA; Mib1 reverse, GGAC-
CAAAAGCCTAACAATCTGGGT; Mist1 forward, TGGTGGCTAAAGC-
TACGTGTC; Mist1 reverse, GACTGGGGTCTGTCAGGTGT; 18S forward, 
CATTCGAACGTCTGCCCTATC; 18S reverse, CCTGTGCCTTCCTTGGA.
Gene chips and bioinformatic analysis. Gene chip arrays used in these experi-
ments were Affymetrix Mouse Gene 1.0ST arrays. Chip quality control and 
GeneChip-to-GeneChip comparisons to generate expression profiles were 
performed using dChip (76, 77). Cell lineage–specific profiles were gener-
ated by extracting those genes whose expression was increased in the given 
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